Literature DB >> 19325623

Targeting the ubiquitin system in cancer therapy.

Daniela Hoeller1, Ivan Dikic.   

Abstract

The ubiquitin system is a network of proteins dedicated to the ubiquitylation of cellular targets and the subsequent control of numerous cellular functions. The deregulation of components of this elaborate network leads to human pathogenesis, including the development of many types of tumour. Alterations in the ubiquitin system that occur during the initiation and progression of cancer are now being uncovered, and this knowledge is starting to be exploited for both molecular diagnostics and the development of novel strategies to combat cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19325623     DOI: 10.1038/nature07960

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  75 in total

1.  The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.

Authors:  Sebastian M B Nijman; Tony T Huang; Annette M G Dirac; Thijn R Brummelkamp; Ron M Kerkhoven; Alan D D'Andrea; René Bernards
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

Review 2.  Alternative UPS drug targets upstream the 26S proteasome.

Authors:  Roland Hjerpe; Manuel S Rodríguez
Journal:  Int J Biochem Cell Biol       Date:  2007-12-08       Impact factor: 5.085

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 4.  P53 and prognosis: new insights and further complexity.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 5.  p53 ubiquitination: Mdm2 and beyond.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

6.  Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.

Authors:  Natalia Issaeva; Przemyslaw Bozko; Martin Enge; Marina Protopopova; Lisette G G C Verhoef; Maria Masucci; Aladdin Pramanik; Galina Selivanova
Journal:  Nat Med       Date:  2004-11-21       Impact factor: 53.440

Review 7.  Proteasome inhibitor, bortezomib, for myeloma and lymphoma.

Authors:  Kensei Tobinai
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

8.  Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells.

Authors:  Hongtao Gu; Xiequn Chen; Guangxun Gao; Hongjuan Dong
Journal:  Mol Cancer Ther       Date:  2008-08       Impact factor: 6.261

9.  Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.

Authors:  J Cummings; M Ranson; E Lacasse; J R Ganganagari; M St-Jean; G Jayson; J Durkin; C Dive
Journal:  Br J Cancer       Date:  2006-07-03       Impact factor: 7.640

10.  The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.

Authors:  Min Sup Song; Leonardo Salmena; Arkaitz Carracedo; Ainara Egia; Francesco Lo-Coco; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2008-08-20       Impact factor: 49.962

View more
  250 in total

Review 1.  Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development.

Authors:  W-L Yang; X Zhang; H-K Lin
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant 'thunder god vine'.

Authors:  Li Lu; Jyoti Kanwar; Sara Schmitt; Qiuzhi Cindy Cui; Chuanyin Zhang; Cong Zhao; Q Ping Dou
Journal:  Anticancer Res       Date:  2011-01       Impact factor: 2.480

3.  Cancer-fighting Smurf.

Authors:  Xi Wang; Charles W M Roberts
Journal:  Nat Med       Date:  2012-02-06       Impact factor: 53.440

4.  Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues.

Authors:  Jesse J Chen; Christopher A Tsu; James M Gavin; Michael A Milhollen; Frank J Bruzzese; William D Mallender; Michael D Sintchak; Nancy J Bump; Xiaofeng Yang; Jingya Ma; Huay-Keng Loke; Qing Xu; Ping Li; Neil F Bence; James E Brownell; Lawrence R Dick
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

Review 5.  Functional proteomics to dissect tyrosine kinase signalling pathways in cancer.

Authors:  Walter Kolch; Andrew Pitt
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

6.  Ubiquitin ligase Siah2 regulates RevErbα degradation and the mammalian circadian clock.

Authors:  Jason P DeBruyne; Julie E Baggs; Trey K Sato; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

7.  Skp2 is required for Aurora B activation in cell mitosis and spindle checkpoint.

Authors:  Juan Wu; Yu-Fan Huang; Xin-Ke Zhou; Wei Zhang; Yi-Fan Lian; Xiao-Bin Lv; Xiu-Rong Gao; Hui-Kuan Lin; Yi-Xin Zeng; Jian-Qing Huang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 8.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

9.  Piperidinyl Ureas Chemically Control Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation.

Authors:  Jared T Hammill; Daniel C Scott; Jaeki Min; Michele C Connelly; Gloria Holbrook; Fangyi Zhu; Amy Matheny; Lei Yang; Bhuvanesh Singh; Brenda A Schulman; R Kiplin Guy
Journal:  J Med Chem       Date:  2018-03-26       Impact factor: 7.446

10.  ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.

Authors:  Ya-Jing Zhuang; Zhi-Wei Liao; Hong-Wei Yu; Xian-Lu Song; Yuan Liu; Xing-Yuan Shi; Xiao-Dan Lin; Tong-Chong Zhou
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.